INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 1 filers reported holding INHIBIKASE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $165,458 | +163.0% | 251,610 | +100.0% | 0.03% | +26.1% |
| Q4 2022 | $62,903 | -43.3% | 125,805 | +2.7% | 0.02% | -43.9% |
| Q3 2022 | $111,000 | +22.0% | 122,477 | -0.2% | 0.04% | +24.2% |
| Q2 2022 | $91,000 | -50.0% | 122,682 | 0.0% | 0.03% | -38.9% |
| Q1 2022 | $182,000 | – | 122,682 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HAMILTON LANE ADVISORS LLC | 13,802 | $50 | 0.02% |